Innovation and Service development

It is well known that certain fruits and vegetables help prevent cardiovascular and inflammatory diseases. Fruit and vegetable extracts have shown to be effective in managing chronic illnesses such as inflammatory diseases and diabetes. A diet high in antioxidants and phenolic compounds is a natural way to prevent certain diseases. Accessible and affordable, Nutra Canada’s extracts are a natural source of antioxidants that provide positive health benefits.

Laboratory/Research in Partnership with our Clients

Nutra Canada, in partnership with Université Laval and the INAF, works closely with its commercial partners on the industrial and scientific development of extracts from its own biomass or that of its clients.
Nutra Canada’s R&D program is devoted to clinical tests aimed at improving processes and exploiting its products.

Nutra Canada’s Clinical Studies

At Nutra Canada, we believe that our product sales are a direct reflection of their quality and the extensive scientific and clinical literature available.
With partners from Quebec and France, Nutra Canada is currently conducting a clinical study on its wild blueberry extract (rich in polyphenols). The study aims to demonstrate how polyphenols from wild blueberry and grape seed extracts affect cognitive health in seniors.
Recently, Nutra Canada completed a clinical study to determine the impact on insulin sensitivity in people at risk of developing Type 1 diabetes. Researchers from Université Laval will soon be publishing the results obtained from cranberry and strawberry extracts with a high concentration of polyphenols (in the form of a drink). Preliminary results suggest an improvement in insulin sensitivity.

A third clinical trial has begun to measure the effects of concentrated cranberry extracts on the prevention of urinary tract infections (UTIs).

The BL-DMAC Analysis Method

Nutra Canada uses a variety of methods (European pharmacopoeia and HPLC) to produce standardized cranberry proanthocyanidins (PACs). Nonetheless, we feel that the BL-DMAC method developed by Brunswick Laboratory (Brunswick, New Jersey, USA) is the most accurate. In addition to being easy to follow, the BL-DMAC method is inexpensive and reproducible, and it measures PACs specifically (unlike other methods which, in addition to measuring PACs, measure other unrelated compounds). For more information, please visit: www.DMAC-ASSO.org.

The Crystal Clear technology

Nutra Canada has developed a new technology that makes molecular extracts 100% soluble and perfectly clear when dissolved in water. This technology uses filtration to remove small insoluble particles which tend to clump together when dissolved in water. This technology has been specially developed to meet the needs of our customers who use our molecular extracts to develop liquid formulations.

Encapsulation

Nutra Canada’s extracts are intrinsically hygroscopic. Do not use around water or in high humidity. It is strongly recommended that the extracts be stored in their original packaging and used immediately upon opening.
Nutra Canada recommends that the instructions be followed for handling, storing, and encapsulation or packaging in pouches.

Storage

Store extracts in their original packaging at 21⁰C or cooler with a relative humidity of 50% or less until ready for use. Under these conditions, Nutra Canada extracts have a shelf life of three years. Pay special attention once the seal has been broken.

Recommended conditions for encapsulation or packaging in pouches:

  • Room with controlled humidity (relative humidity: < 50%)
  • Room temperature: ≤ 21⁰C
  • Before encapsulation or packaging in pouches, ensure machines are perfectly dry and free of water. You may apply a fine coat of an anticaking agent (calcium triphosphate or silicon dioxide) to the equipment.
  • Add a silica gel packet to bottles containing capsules.
  • Adding certain additives to the powder before encapsulation or putting into pouches may also improve the fluidity of the powder for the procedure.

Recommended additives:

  • Magnesium stearate or calcium stearate (< 1% concentration in the end product)
  • Silicon dioxide (< 0.2% concentration in the end product)